-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$48.7117.88% Upside
Agios Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. has been rated by research analysts at Leerink Partners, Raymond James, RBC Capital, Piper Sandler, J.P. Morgan, Goldman Sachs in the past 90 days.